Ro 31-8959 proteinase inhibitor: Began a 40-center, U.S. Phase III trial in 1200 patients with advanced HIV who have had previous AZT therapy and have CD4 cell

Hoffmann-La Roche Inc., Nutley, N.J.
Product: Ro

Read the full 72 word article

How to gain access

Continue reading with a
two-week free trial.